AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2021
Aug 17, 2021
33153_dirs_2021-08-17_d67e2ded-c54b-478a-8e5c-ed94b79b0f43.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO/ (mlab)
CIK: 0000724004
Period of Report: 2021-08-16
Reporting Person: Sullivan John James (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-16 | Common Stock | M | 5192 | $89.7 | Acquired | 28549 | Direct |
| 2021-08-16 | Common Stock | S | 5192 | $272.16 | Disposed | 23357 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-16 | Non Qualified Stock Option | $89.7 | X | 5192 | Disposed | 2022-04-01 | Common Stock (5192) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 30000 | Indirect |
Footnotes
F1: 1/7 exercisable on each anniversary date of the 04-01-2014 grant date
F2: Represents gift of shares to a spousal lifetime access trust
More from MESA LABORATORIES INC /CO/
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6
Regulatory Filings
2025
Nov 6